Loading
Medprin Regenerative Medical Technologies Co., Ltd. Stock: price and insider trades · China
迈普医学
No insider purchase over the last 90 days. The latest was filed 22 May 2024.
Medprin Regenerative Medical Technologies Co., Ltd.: what insiders have been doing
Medprin Regenerative Medical Technologies Co., Ltd., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SSE / SZSE (CSRC). No insider at Medprin Regenerative Medical Technologies Co., Ltd. has published a filing in the past twelve months. The most recent one dates from 22 May 2024.
Over the whole record (from 2022), the tally stands at 4 purchases and 2 sales.
Other companies in the same sector with recent insider buying flagged by our signals: MAIA Biotechnology, Inc. and Cooper Companies, Inc. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.
Insider Decl.
6
Thresholds
n/a
Buy Volume
€147,359
4 ops. · all time
Sell Volume
€1M
2 ops. · all time
Since the insiders bought
- +55.2%Entry CN¥41.33 · Close at T+365 CN¥64.13
- +65.0%Entry CN¥28.43 · Close at T+365 CN¥46.92
- +65.0%Entry CN¥28.43 · Close at T+365 CN¥46.92
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 4,991 of 24,161 companies
66.5
score / 100
Value42
Quality91
FCF yld3.2%
Earn yld3.1%
EV/EBITDA23.6x
ROE16%
Gross mgn80%
Net mgn31%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CN¥53.66
Analyst consensus
Income statement
RevenueCN¥368.8M
Gross profitCN¥295.9M80% margin
EBITDACN¥153.7M42% margin
Net incomeCN¥113.1M30.5% margin
Valuation
PER (trailing)29.5x
P/Book4.4x
Beta-0.11
Balance sheet & cash
Market capCN¥3.6B
Total debtCN¥1M
Free Cash FlowCN¥116M
Debt / Equity1%
Profitability & ownership
ROE16.0%
ROA9.3%
% insiders45.2%
% institutions13.8%
Last declaration on 22 May 2024
Declarations6 total
6 of 6 declarations
About Medprin Regenerative Medical Technologies Co., Ltd.
迈普医学 is a company specializing in the healthcare and pharmaceutical sector, providing innovative solutions for diagnosis and treatment. It is listed on the XSHE market.
